menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Estrogen and Heart Health: What We Believe Now

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.

Facebook Comments

Schedule19 Apr 2024